YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.

"We have seen an alarming rise in diabetes over the past three decades, which reflects the increase in obesity, compounded by the impacts of the marketing of unhealthy food, a lack of physical ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo and Lego on top, PostNord and Coop at the bottom. The Institute for Opinion Analysis (Instituttet for Opinionsanalyse) ...

Bagsværd, Denmark, 13 November 2024 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk ...

Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...

The forecast was 2.6%. Denmark's Novo Nordisk spiked 7.8% in early trading to DKK803.5. The group announced its 3Q results, ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...